The diagnosis of ovarian cancer often occurs in the late stages due to a lack of adequate screening facilities. However, it is coming to light that the patients quality of life may be just as important as the therapy that they are receiving when it comes to treating the disease. Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Jalid Sehouli, MD, of the Charité Comprehensive Center, Berlin, Germany, explains how patient care and quality of life can have an impact on survival. Dr Sehouli describes a recent meta-analysis his research group conducted to determine whether there is a correlation between patient quality of life and overall survival, and mentions some of the interesting results they obtained.
Quality of life can impact PFS in ovarian cancer
